tiprankstipranks
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market

Enlivex (ENLV) Income Statement

Compare
421 Followers

Enlivex Income Statement

Last quarter (Q3 2024), Enlivex's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Enlivex's net income was $-2.60M. See Enlivex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 2.28M$ 0.00
Gross Profit
$ -835.00K$ -777.00K$ -546.00K$ 1.99M$ -297.00K
Operating Expenses
$ 29.39M$ 25.80M$ 19.29M$ 9.79M$ 8.62M
Depreciation and Amortization
$ 835.00K$ 777.00K$ 546.00K$ 286.00K$ 297.00K
EBITDA
$ -28.22M$ -25.02M$ -18.74M$ -9.50M$ -9.08M
Operating Income
$ -29.39M$ -25.80M$ -19.29M$ -9.79M$ -8.62M
Other Income/Expenses
$ 327.00K$ -5.26M$ 4.82M$ -2.04M$ -765.00K
Pretax Income
$ -29.07M$ -31.06M$ -14.47M$ -11.82M$ -9.38M
Net Income
$ -29.07M$ -42.41M$ -9.65M$ -13.86M$ -10.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.56$ -2.31$ -0.54$ -1.05$ -1.17
Diluted EPS
$ -1.56$ -2.31$ -0.54$ -1.05$ -1.17
Weighted Average Shares Outstanding
18.57M 18.39M 17.86M 13.17M 8.65M
Weighted Average Shares Outstanding (Diluted)
18.57M 18.39M 17.86M 13.17M 8.65M
Currency in USD

Enlivex Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis